欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/V/0426/001
药品名称
Vigophos 100/0,05 mg/ml
活性成分
butafosfan 100.0 mg/ml
cyanocobalamin 0.05 mg/ml
剂型
Solution for injection
上市许可持有人
aniMedica GmbH
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Germany (DE)
Vigophos
Denmark (DK)
Vigophos
Belgium (BE)
Vigophos
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Vigophos 100 mg/ml + 0,05 mg/ml Injektionslösung für Rinder
Spain (ES)
Portugal (PT)
Italy (IT)
Sweden (SE)
Poland (PL)
Hungary (HU)
Czechia (CZ)
Romania (RO)
Slovakia (SK)
Slovenia (SI)
许可日期
2018/02/01
最近更新日期
2024/06/06
药物ATC编码
QA12CX91 butafosfan
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
vigophos_1b_spc_pl_vs002_proposed_clean
Date of last change:2024/09/06
PubAR
|
2402428_paren_20211104
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase